Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neuroscience Methods

• Publication date

  2009-03-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.JNEUMETH.2008.10.038PMID 19263575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum cystatin C and the risk of Alzheimer disease in elderly men

  2008cited by this paper
• Cystatin C: a potential target for Alzheimer’s treatment

  2008cited by this paper
• Protein accumulation in traumatic brain injury

  2007cited by this paper
• Mass Spectrometry Based Strategies in Quantitative Proteomics

  2006cited by this paper
• Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats*

  2006cited by this paper
• Evaluation of pharmacological treatment strategies in traumatic brain injury.

  2006cited by this paper
• Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome.

  2006cited by this paper
• Translational Neurochemical Research in Acute Human Brain Injury: The Current Status and Potential Future for Cerebral Microdialysis

  2005cited by this paper
• Proteomic identification of biomarkers of traumatic brain injury

  2005cited by this paper
• A multidimensional differential proteomic platform using dual-phase ion-exchange chromatography-polyacrylamide gel electrophoresis/reversed-phase liquid chromatography tandem mass spectrometry.

  2005cited by this paper
• Clinical Proteomics: From Biomarker Discovery and Cell Signaling Profiles to Individualized Personal Therapy

  2005cited by this paper
• Nanoflow liquid chromatography coupled to matrix‐assisted laser desorption/ionization mass spectrometry: Sample preparation, data analysis, and application to the analysis of complex peptide mixtures

  2005cited by this paper
• Rapid Discovery of Putative Protein Biomarkers of Traumatic Brain Injury by SDS–PAGE–Capillary Liquid Chromatography–Tandem Mass Spectrometry

  2005cited by this paper
• Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.

  2004cited by this paper
• GFAP Versus S100B in Serum after Traumatic Brain Injury: Relationship to Brain Damage and Outcome

  2004cited by this paper
• Biomarkers of Proteolytic Damage Following Traumatic Brain Injury

  2004cited by this paper
• Marked increase of β-amyloid(1–42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury

  2004cited by this paper
• Proteome Study of Human Cerebrospinal Fluid following Traumatic Brain Injury Indicates Fibrin(ogen) Degradation Products as Trauma-Associated Markers

  2004cited by this paper
• Proteomics studies of traumatic brain injury.

  2004cited by this paper
• Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S

  2004cited by this paper
• Biochemical serum markers for brain damage: A short review with emphasis on clinical utility in mild head injury

  2003cited by this paper
• The Epidemiology of Traumatic Brain Injury: A Review

  2003cited by this paper
• Application of Proteomics Technology to the Field of Neurotrauma

  2003cited by this paper
• Cerebrospinal Fluid Apolipoprotein E Concentration Decreases after Traumatic Brain Injury

  2003cited by this paper
• Peptide mapping of proteins in human body fluids using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.

  2002cited by this paper
• Outcome after traumatic brain injury improved by an organized secondary insult program and standardized neurointensive care*

  2002cited by this paper
• Clinical Trials in Head Injury

  2002cited by this paper
• Conventional and Functional Proteomics Using Large Format Two-Dimensional Gel Electrophoresis 24 Hours after Controlled Cortical Impact in Postnatal Day 17 Rats

  2002cited by this paper
• Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.

  2002cited by this paper
• S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury.

  2001cited by this paper
• Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats.

  2001cited by this paper
• S-100β Reflects the Extent of Injury and Outcome, Whereas Neuronal Specific Enolase Is a Better Indicator of Neuroinflammation in Patients With Severe Traumatic Brain Injury

  2001cited by this paper
• Accumulation of non‐erythroid αII‐spectrin and calpain‐cleaved αII‐spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats

  2001cited by this paper
• Probing proteomes—seeing the whole picture?

  2000cited by this paper
• Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology.

  2000cited by this paper
• Mass spectrometry and proteomics.

  2000cited by this paper
• Serum markers of brain damage and outcome prediction in patients after severe head injury.

  1999cited by this paper
• Proteome and proteomics: New technologies, new concepts, and new words

  1998cited by this paper
• Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

  1998cited by this paper
• Neuron-specific enolase as an aid to outcome prediction in head injury.

  1996cited by this paper
• Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries.

  1995cited by this paper
• Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury.

  1995cited by this paper
• Neuron-specific enolase in gerbil brain and serum after transient cerebral ischemia.

  1995cited by this paper
• Mild traumatic brain injury

  1995cited by this paper
• A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults.

  1994cited by this paper
• A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children.

  1992cited by this paper
• Clinical biochemistry of neuron specific enolase.

  1989cited by this paper
• Extravasation of plasma proteins in brain trauma.

  1988cited by this paper
• Severe head trauma and the changes of concentration of neuron-specific enolase in plasma and in cerebrospinal fluid.

  1983cited by this paper

• Inflammatory Mediators Related to Vascular Dysfunction are Linked to ICP, PRx, and CPP Following Human Severe Traumatic Brain Injury

  2025cites this paper
• Time-Dependent Changes in the Biofluid Levels of Neural Injury Markers in Severe Traumatic Brain Injury Patients–Cerebrospinal Fluid and Cerebral Microdialysates: A Longitudinal Prospective Pilot Study

  2023influential citation
• Research progress in the application of proteomics technology in brain injury.

  2023cites this paper
• The Cerebrospinal Fluid Proteomic Response to Traumatic and Nontraumatic Acute Brain Injury: A Prospective Study

  2022cites this paper
• Integrative Neuroinformatics for Precision Prognostication and Personalized Therapeutics in Moderate and Severe Traumatic Brain Injury

  2021cites this paper
• A nomogram based on serum cystatin C for predicting acute kidney injury in patients with traumatic brain injury

  2021cites this paper
• Fluid Proteomics of CSF and Serum Reveal Important Neuroin�ammatory Proteins in Blood-Brain Barrier Disruption and Outcome Prediction following Severe Traumatic Brain Injury: a Prospective, Observational Study

  2020cites this paper
• Serum cystatin C was a marker of poststroke fatigue in hypertensive intracerebral hemorrhage

  2020cites this paper
• Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood–brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study

  2020cites this paper
• Metabolomics in postmortem cerebrospinal fluid diagnostics: a state-of-the-art method to interpret central nervous system–related pathological processes

  2020cites this paper
• Blood-Related Toxicity after Traumatic Brain Injury: Potential Targets for Neuroprotection

  2019cites this paper
• Post-mortem cerebrospinal fluid diagnostics: cytology and immunocytochemistry method suitable for routine use to interpret pathological processes in the central nervous system

  2019cites this paper
• Measurement of Cerebral Biomarkers Proving Traumatic Brain Injuries in Post-Mortem Body Fluids

  2018cites this paper
• Acute phase response after fatal traumatic brain injury

  2018cites this paper
• Post-mortem in situ stability of serum markers of cerebral damage and acute phase response

  2018cites this paper
• Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?

  2018cites this paper
• Dietary Zinc Modulates Matrix Metalloproteinases in Traumatic Brain Injury

  2018cites this paper
• Proteomic differences between focal and diffuse traumatic brain injury in human brain tissue

  2018cites this paper
• New astroglial injury-defined biomarkers for neurotrauma assessment

  2017cites this paper
• Quantitative Proteomic Study Reveals Up-Regulation of cAMP Signaling Pathway-Related Proteins in Mild Traumatic Brain Injury.

  2017cites this paper
• Current and Emerging Technologies for Probing Molecular Signatures of Traumatic Brain Injury

  2017influential citation
• The Application of Proteomics to Traumatic Brain and Spinal Cord Injuries

  2017cites this paper
• Quantitative proteomics analysis to identify diffuse axonal injury biomarkers in rats using iTRAQ coupled LC-MS/MS.

  2016cites this paper
• Current status of fluid biomarkers in mild traumatic brain injury.

  2016cites this paper
• Association between apoptotic neural tissue and cell proliferation in the adult teleost brain.

  2016cites this paper
• Traumatically injured astrocytes release a proteomic signature modulated by STAT3‐dependent cell survival

  2016cites this paper
• Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease.

  2015cites this paper
• Protein Biomarkers in Traumatic Brain Injury: An Omics Approach

  2014cites this paper
• Blood-based biomarkers for traumatic brain injury: evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives.

  2014cites this paper
• Addressing the needs of traumatic brain injury with clinical proteomics

  2014cites this paper
• Neuro-proteomics and Neuro-systems Biology in the Quest of TBI Biomarker Discovery

  2014cites this paper
• S100B and NSE as Useful Postmortem Biochemical Markers of Traumatic Brain Injury in Autopsy Cases

  2013cites this paper
• Integration of Proteomics, Bioinformatics, and Systems Biology in Traumatic Brain Injury Biomarker Discovery

  2013cites this paper
• Detection of Structural and Metabolic Changes in Traumatically Injured Hippocampus by Quantitative Differential Proteomics

  2013cites this paper
• Time‐dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury

  2012cites this paper
• Principal Component Analysis of the Cytokine and Chemokine Response to Human Traumatic Brain Injury

  2012cites this paper
• Multiplexed quantification of proteins adsorbed to surface-modified and non-modified microdialysis membranes

  2012cites this paper
• High‐capacity peptide‐centric platform to decode the proteomic response to brain injury

  2012cites this paper
• Proteome analysis of human cerebrospinal fluid as a diagnostic biomarker in patients with meningioma

  2012cites this paper
• Clinical neuroproteomics and biomarkers: from basic research to clinical decision making.

  2012cites this paper
• Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke

  2012cites this paper
• The proteomic toolbox for studying cerebrospinal fluid

  2012cites this paper
• Proteomic Analysis of Cerebrospinal Fluid in a Fulminant Case of Multiple Sclerosis

  2012cites this paper
• Dynamic measurement of soluble human Abeta in a combined microdialysis-experimental traumatic brain injury mouse model

  2011cites this paper
• Sample Preparation of Primary Astrocyte Cellular and Released Proteins for 2-D Gel Electrophoresis and Protein Identification by Mass Spectrometry

  2011cites this paper
• Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum*

  2011cites this paper
• Biomarker Discovery in Biological Fluids

  2011cites this paper
• Neuroproteomics: A Biochemical Means To Discriminate the Extent and Modality of Brain Injury

  2010cites this paper
• Methodological aspects on microdialysis protein sampling and quantification in biological fluids: an in vitro study on human ventricular CSF.

  2010cites this paper
• Confident assignment of intact mass tags to human salivary cystatins using top-down Fourier-transform ion cyclotron resonance mass spectrometry

  2010cites this paper
• Assessment of the partitioning capacity of high abundant proteins in human cerebrospinal fluid using affinity and immunoaffinity subtraction spin columns.

  2010cites this paper
• Determination of cerebrospinal fluid cystatin C on Architect ci8200.

  2010cites this paper
• Metabolic Crisis After Traumatic Brain Injury is Associated with a Novel Microdialysis Proteome

  2010influential citation
• Mining ventricular cerebrospinal fluid from patients with traumatic brain injury using hexapeptide ligand libraries to search for trauma biomarkers.

  2010cites this paper
• Production of Cystatin C Wild Type and Stabilized Mutants

  2010cites this paper
• Head and neck cancer

  2010cites this paper
• CE MALDI‐TOF/TOF MS for multiplexed quantification of proteins in human ventricular cerebrospinal fluid

  2009cites this paper
• Mini Review Article

  year unknowncites this paper